Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
about
Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable anginaHemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analysesCirculating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomesTraditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infectionEvidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events.Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.Exploring the complexity of cardiometabolic risk in women.Pro-coagulant activity during exercise testing in patients with coronary artery disease.Association between platelet to lymphocyte ratio and saphenous vein graft disease in patients with stable angina pectoris.Can haemostatic factors predict atherothrombosis?Viral serpin therapeutics from concept to clinic.Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.HIV-positive youth who are perinatally infected have impaired endothelial function.Aorta structural alterations in term neonates: the role of birth and maternal characteristics.Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study.Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults.Use of reclassification for assessment of improved prediction: an empirical evaluation.
P2860
Q26859111-73481D2D-0248-4C40-9049-73025C28718DQ26993237-0459B3A6-0CC7-4A19-ABB5-18C5390A2968Q33606548-748A339F-9DC9-4DA3-AF6A-2C7247725716Q33791968-1DE06E23-81D0-41CA-9034-78685D428E04Q33907642-392E2520-233D-462C-8AB0-34FF7AE61116Q34562507-6C8C9155-A995-483F-96C3-86E09CFA9AAEQ35215601-45371AF5-D421-404D-A90C-7B19860EAA41Q37146009-0E7E8D8B-12A5-48CF-AFBC-87403E13C0E1Q37595481-261244AE-3F2A-4074-A2D3-7E4EE6B340C0Q37680325-CF8F2E3A-2C77-4002-AD12-71482D8601C8Q37843765-7900F127-8BEF-4BB0-8D4C-7874F1306051Q37891258-D51B6EA5-DBF3-40C8-B9EC-C33DA60EE663Q38747883-77AADCD1-86E2-46C0-A9A2-5E59244DB10AQ40181907-9FD06E00-2DA3-42C5-ADB0-C5AF58CC4309Q41812258-E0399FD3-6B60-49E3-B8D3-738C49AE1BF1Q44072036-F274E09A-067E-4F43-BD8C-26F0B10399A8Q45191361-36377AE3-5837-4A00-A9DB-3188546DEDDCQ46938393-C203263E-BF65-4C07-84BF-A72F8F37DD92
P2860
Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@en
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@nl
type
label
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@en
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@nl
prefLabel
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@en
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@nl
P2093
P50
P356
P1476
Contribution of novel biomarke ...... ary syndrome: the PRIME Study.
@en
P2093
Alun Evans
Annie Bingham
Bernadette Haas
Dominique Arveiler
Gerald Luc
Irene Juhan-Vague
Jean-Philippe Empana
Michelle Montaye
PRIME Study Group
Pierre Ducimetiere
P304
P356
10.1093/EURHEARTJ/EHN331
P577
2008-07-10T00:00:00Z